سعر اكماسونيد 9 مجم 10 أقراص مغلفة ممتدة المفعول 2025

Ekmasonid 9 mg budesonide extended-release film-coated tablets, 10 tablets (Hikma Pharma).

• Induction of remission in adults with active mild to moderate ulcerative colitis (US UCERIS 9 mg ER).Population: AdultsDailyMed / FDA

• Most common (≥2%): headache, nausea, decreased blood cortisol, upper abdominal pain, fatigue, flatulence, abdominal distension, acne, UTI, arthralgia, constipation (US UCERIS trials).International label, same formulation · DailyMed / FDA

• Known hypersensitivity to budesonide or any tablet ingredients (US UCERIS).International label, same formulation · DailyMed / FDA

• Hypercorticism and adrenal suppression may occur; immunosuppression and infection risk including TB reactivation, varicella/measles; Kaposi sarcoma reported with corticosteroids (US UCERIS).International label, same formulation · DailyMed / FDA
• Avoid CYP3A4 inhibitors (e.g. ketoconazole) and grapefruit; monitor hepatic impairment for hypercorticism (US UCERIS).International label, same formulation · DailyMed / FDA

• Based on animal data, may cause fetal harm; hypoadrenalism may occur in infants of mothers receiving corticosteroids (US UCERIS).International label, same formulation · DailyMed / FDA

• Budesonide: Potent glucocorticoid receptor agonist with high first-pass hepatic metabolism; ER coating releases in distal intestine.